SCHEMBL19544726

SCHEMBL19544726

Cn1cc(-c2cc(C(=O)Nc3ccc(OC(F)(F)Cl)cc3)cnc2Cl)cn1

nearest known ligand 0.71

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 20/20 0.71
▸ KCNH2 Q12809 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19545182 0.91 ABL1 (0.65) ABL1KCNH2
SCHEMBL24850863 0.85 ABL1 (0.68) ABL1
SCHEMBL19545250 0.85 ABL1 (0.68) ABL1KCNH2
SCHEMBL19520199 0.84 ABL1 (0.59) ABL1KCNH2
SCHEMBL19520206 0.83 ABL1 (0.60) ABL1KCNH2
SCHEMBL15391148 0.83 ABL1 (1.00) ABL1KCNH2
SCHEMBL19544985 0.82 ABL1 (0.77) ABL1
SCHEMBL19520198 0.82 ABL1 (0.62) ABL1
SCHEMBL19544762 0.82 ABL1 (0.65) ABL1KCNH2
SCHEMBL15391435 0.82 ABL1 (1.00) ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017186148-A1 NOVEL HETEROCYCLIC COMPOUNDS AS TYROSINE KINASE BCR-ABL INHIBITORS ASTAR BIOTECH LLC (US) 2017-11-02 — — WO disclosed
Send feedback